<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Neutropenic Fever and Cancer</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->10/7/2011</div></div><div class="card__content"><h1 id="neutropenic-fever-and-cancer">Neutropenic Fever and Cancer</h1>
<p>Chemotherapy causes neutropenia in 10-50% of patients with solid tumors and &gt; 80% of patients with hematologic malignancies during chemotherapy cycle</p>
<p><strong>Fever:</strong> &ge; 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period</p>
<p><strong>Neutropenia:</strong> Absolute neutrophil count &lt; 500 cells/mm3</p>
<h2 id="mascc-score">MASCC score</h2>
<p><strong>Multinational Association for Supportive Care in Cancer (MASCC) Score</strong></p>
<table>
<thead>
<tr>
<th>Criteria</th>
<th align="right">Points</th>
</tr>
</thead>
<tbody><tr>
<td>Burden of febrile neutropenia</td>
<td align="right">5 (if mild) or 3 (if moderate)</td>
</tr>
<tr>
<td>No hypotension (SBP ≥ 90 mmHg)</td>
<td align="right">5</td>
</tr>
<tr>
<td>No COPD</td>
<td align="right">4</td>
</tr>
<tr>
<td>Solid tumor or hematologic malignancy <span class="drug">with</span> no previous fungal infection</td>
<td align="right">4</td>
</tr>
<tr>
<td>No dehydration requiring parenteral fluids</td>
<td align="right">3</td>
</tr>
<tr>
<td>Outpatient status</td>
<td align="right">3</td>
</tr>
<tr>
<td>Age &lt;60 years</td>
<td align="right">2</td>
</tr>
</tbody></table>
<h3 id="high-risk-patients-require-admission-">High Risk Patients (require admission)</h3>
<ul>
<li>MASCC score &lt;21 <strong>OR</strong></li>
<li>Any of clinical findings:<ul>
<li>Prolonged (&gt;7 days duration) and profound neutropenia (ANC ≤100 cells/mm3)</li>
<li>Hypotension</li>
<li>Pneumonia</li>
<li>New abdominal pain</li>
<li>Neurologic changes</li>
</ul>
</li>
</ul>
<h3 id="low-risk-patients-may-be-eligible-for-outpatient-tx-">Low Risk Patients (may be eligible for outpatient tx)</h3>
<ul>
<li>MASCC score &ge;21</li>
<li>Brief (&le;7 days duration) neutropenic periods and few co-morbidities</li>
</ul>
<h2 id="workup">Workup</h2>
<ul>
<li>CBC, BUN/creatinine, electrolytes, AST/ALT, bilirubin</li>
<li>Chest xray, if respiratory signs or symptoms</li>
<li>2 blood cultures (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)</li>
</ul>
<h2 id="antibiotic-treatment">Antibiotic Treatment</h2>
<h3 id="monotherapy">Monotherapy</h3>
<ul>
<li>Antipseudomonal beta-lactam (eg. <span class="drug">cefipime</span>, <span class="drug">carbapenem</span>, <span class="drug">pip-tazo</span>)</li>
<li><span class="drug">Vancomycin</span> is not always indicated in cancer patients with a neutropenic fever.</li>
<li>Add <strong>vancomycin</strong> only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant <em>Strep pneumoniae</em></li>
<li><em>For penicillin allergy</em>: <span class="drug">Ciprofloxacin</span> + <span class="drug">clindamycin</span>, or <span class="drug">aztremonam</span> + <span class="drug">vancomycin</span></li>
<li><em>Oral medication options for outpatient</em>: <span class="drug">Ciprofloxacin</span> + <span class="drug">amoxicillin-clavulanate</span></li>
</ul>
<h2 id="central-line-associated-blood-stream-infection-clabsi-">Central line-associated blood stream infection (CLABSI)</h2>
<p><strong>Remove catheter:</strong> Consider removal if any of following: </p>
<ul>
<li>Caused by <em>S. aureus</em>, <em>P. aeruginosa</em>, fungi, mycobacteria</li>
<li>Tunnel infection</li>
<li>Pocket site infection</li>
<li>Septic thrombosis</li>
<li>Endocarditis</li>
<li>Sepsis with hemodynamic instability</li>
<li>Bacteremia despite ≥72 hours of antibiotics</li>
</ul>
<p><strong>Keep catheter</strong> and treat with antiobitics: If coagulase-negative staph</p>
<h2 id="references">References</h2>
<ul>
<li>Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21205990">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"cancer-neutropenic-fever","title":"Neutropenic Fever and Cancer","authors":["Michelle Lin, MD"],"categories":[{"slug":"hematology-and-oncology","name":"Hematology and Oncology"}],"created":"2011/10/07","updated":"2017/05/10","body":"\n# Neutropenic Fever and Cancer\n\nChemotherapy causes neutropenia in 10-50% of patients with solid tumors and \u003e 80% of patients with hematologic malignancies during chemotherapy cycle\n\n**Fever:** \u0026ge; 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period\n\n**Neutropenia:** Absolute neutrophil count \u0026lt; 500 cells/mm3\n\n## MASCC score\n\n**Multinational Association for Supportive Care in Cancer (MASCC) Score**\n\n| Criteria                                                                                          |                         Points |\n| ------------------------------------------------------------------------------------------------- | -----------------------------: |\n| Burden of febrile neutropenia                                                                     | 5 (if mild) or 3 (if moderate) |\n| No hypotension (SBP ≥ 90 mmHg)                                                                    |                              5 |\n| No COPD                                                                                           |                              4 |\n| Solid tumor or hematologic malignancy \u003cspan class=\"drug\"\u003ewith\u003c/span\u003e no previous fungal infection |                              4 |\n| No dehydration requiring parenteral fluids                                                        |                              3 |\n| Outpatient status                                                                                 |                              3 |\n| Age \u0026lt;60 years                                                                                  |                              2 |\n\n### High Risk Patients (require admission)\n\n- MASCC score \u0026lt;21 **OR**\n- Any of clinical findings:\n  - Prolonged (\u003e7 days duration) and profound neutropenia (ANC ≤100 cells/mm3)\n  - Hypotension\n  - Pneumonia\n  - New abdominal pain\n  - Neurologic changes\n\n### Low Risk Patients (may be eligible for outpatient tx)\n\n- MASCC score \u0026ge;21\n- Brief (\u0026le;7 days duration) neutropenic periods and few co-morbidities\n\n## Workup\n\n- CBC, BUN/creatinine, electrolytes, AST/ALT, bilirubin\n- Chest xray, if respiratory signs or symptoms\n- 2 blood cultures (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)\n\n## Antibiotic Treatment\n\n### Monotherapy\n\n- Antipseudomonal beta-lactam (eg. \u003cspan class=\"drug\"\u003ecefipime\u003c/span\u003e, \u003cspan class=\"drug\"\u003ecarbapenem\u003c/span\u003e, \u003cspan class=\"drug\"\u003epip-tazo\u003c/span\u003e)\n- \u003cspan class=\"drug\"\u003eVancomycin\u003c/span\u003e is not always indicated in cancer patients with a neutropenic fever.\n- Add **vancomycin** only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant _Strep pneumoniae_\n- _For penicillin allergy_: \u003cspan class=\"drug\"\u003eCiprofloxacin\u003c/span\u003e + \u003cspan class=\"drug\"\u003eclindamycin\u003c/span\u003e, or \u003cspan class=\"drug\"\u003eaztremonam\u003c/span\u003e + \u003cspan class=\"drug\"\u003evancomycin\u003c/span\u003e\n- _Oral medication options for outpatient_: \u003cspan class=\"drug\"\u003eCiprofloxacin\u003c/span\u003e + \u003cspan class=\"drug\"\u003eamoxicillin-clavulanate\u003c/span\u003e\n\n## Central line-associated blood stream infection (CLABSI)\n\n**Remove catheter:** Consider removal if any of following: \n\n- Caused by _S. aureus_, _P. aeruginosa_, fungi, mycobacteria\n- Tunnel infection\n- Pocket site infection\n- Septic thrombosis\n- Endocarditis\n- Sepsis with hemodynamic instability\n- Bacteremia despite ≥72 hours of antibiotics\n\n**Keep catheter** and treat with antiobitics: If coagulase-negative staph\n\n## References\n\n- Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21205990)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"cancer-neutropenic-fever"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>